4 comments By Julie Grisham, MS, Science Writer/Editor   |  Wednesday, March 13, 2013 Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. read more

See the article here:
New Molecule Targets Proteins Inside Cancer Cells

Scroll to Top